(Q34011489)

English

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

30 July 2017

Idiotype-pulsed antigen-presenting cells following autologous transplantation for multiple myeloma may be associated with prolonged survival (English)

1 reference

Europe PubMed Central

30 July 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

7

object named as

David Dingli

1 reference

Europe PubMed Central

30 July 2017

Angela Dispenzieri

3

object named as

Angela Dispenzieri

1 reference

Europe PubMed Central

30 July 2017

1

object named as

Martha Q Lacy

1 reference

Europe PubMed Central

30 July 2017

S. Vincent Rajkumar

13

object named as

S Vincent Rajkumar

1 reference

Europe PubMed Central

30 July 2017

14

object named as

Morie A Gertz

1 reference

Europe PubMed Central

30 July 2017

Suzanne R Hayman

4

object named as

Suzanne Hayman

1 reference

Europe PubMed Central

30 July 2017

8

object named as

Mark Litzow

1 reference

Europe PubMed Central

30 July 2017

Francis K Buadi

6

object named as

Francis Buadi

1 reference

Europe PubMed Central

30 July 2017

5

object named as

Shaji Kumar

1 reference

Europe PubMed Central

30 July 2017

11

object named as

Brian Kabat

1 reference

Europe PubMed Central

30 July 2017

Dennis A Gastineau

12

object named as

Dennis Gastineau

1 reference

Europe PubMed Central

30 July 2017

author name string

Sumithra Mandrekar

2

1 reference

Europe PubMed Central

30 July 2017

Peter Wettstein

9

1 reference

Europe PubMed Central

30 July 2017

Douglas Padley

10

1 reference

Europe PubMed Central

30 July 2017

publication date

1 December 2009

1 reference

Europe PubMed Central

30 July 2017

American Journal of Hematology

1 reference

Europe PubMed Central

30 July 2017

84

1 reference

Europe PubMed Central

30 July 2017

12

1 reference

Europe PubMed Central

30 July 2017

799-802

1 reference

Europe PubMed Central

30 July 2017

Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Combination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Tumor-specific idiotype vaccines in the treatment of patients with B-cell lymphoma--long-term results of a clinical trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Transfer of myeloma idiotype-specific immunity from an actively immunised marrow donor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

5 July 2018

Long-term results of response to therapy, time to progression, and survival with lenalidomide plus dexamethasone in newly diagnosed myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

29 October 2018

Immunotherapy with autologous antigen presenting cells for the treatment of androgen independent prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

29 October 2018

Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

29 October 2018

The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

29 October 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908015

29 October 2018

Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunoglobulin synthesis and tumor kinetics of multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural killer cell activity in monoclonal gammopathies: Relation to disease activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating blood B cells in multiple myeloma: analysis and relationship to circulating clonal cells and clinical parameters in a cohort of patients entered on the Eastern Cooperative Oncology Group phase III E9486 clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotype vaccination in human myeloma: generation of tumor-specific immune responses after high-dose chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Idiotypic protein-pulsed dendritic cell vaccination in multiple myeloma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19899131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/AJH.21560

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

1 reference

Europe PubMed Central

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34011489&oldid=1972812581"